216
Views
19
CrossRef citations to date
0
Altmetric
Original papers

Ski patrollers: Reluctant role models for helmet use

, , , &
Pages 9-14 | Received 24 Sep 2008, Accepted 06 Jan 2009, Published online: 18 Mar 2009
 

Abstract

Ski helmets reduce the risk of traumatic brain injury (TBI), but usage rates are low. Ski patrollers could serve as role models for helmet use, but little is known about their practices and beliefs. A written survey was distributed to ski patrollers attending continuing education conferences. The questions addressed included helmet use rates, prior TBI experiences, perceptions of helmet risks and benefits and willingness to serve as safety role models for the public. To assess predictors of helmet use, odds ratios (OR) were calculated, after adjusting for skiing experience. Ninety-three ski patrollers participated and the main outcome was self-reported helmet use of 100% while patrolling. Helmet use was 23% (95% CI 15–32%). Common reasons for non-use included impaired hearing (35%) and discomfort (29%). Most patrollers believed helmets prevent injuries (90%; 95% CI 84–96%) and that they are safety role models (92%; 95% CI 86–98%). However, many believed helmets encourage recklessness (39%; 95% CI 29–49%) and increase injury risks (16%; 95% CI 7–25%). Three factors predicted 100% helmet use: perceived protection from exposure (OR = 9.68; 95% CI 3.14–29.82) or cold (OR = 5.68; 95% CI 1.27–25.42); and belief that role modelling is an advantage of helmets (OR = 4.06; 95% CI 1.29–12.83). Patrollers who believed helmets encourage recklessness were eight times less likely to wear helmets (OR = 0.13; 95% CI 0.03–0.58). Ski patrollers know helmets reduce serious injury and believe they are role models for the public, but most do not wear helmets regularly. To increase helmet use, manufacturers should address hearing- and comfort-related factors. Education programmes should address the belief that helmets encourage recklessness and stress role modelling as a professional responsibility.

Acknowledgements

Dr. Lowenstein is supported in part by Grant Number R49/CCR811509 from the Centers for Disease Control and Prevention (CDCP). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the CDCP. Dr. Heard is supported in part by Grant No. DA020573 from the National Institute on Drug Abuse.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.